Article
Neoepitopes as Difference Makers for General Cancer Vaccines?
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Sept 2020
Filderman Jessica N, Storkus Walter J
Abstract excerpt
The cancer mutanome has been associated with disease prognosis as well as response to interventional immunotherapy and provides a substrate for development of personalized vaccines targeting tumor neoepitopes. Recent findings suggest that neoantigen-based vaccines may represent general interventional approaches for patients with solid cancers, regardless of their inherent mutational burden.See related article by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
